Yirui Wang Selected Research

Yirui Wang Research Topics

Disease

9	Neoplasms (Cancer) 01/2024 - 10/2020
5	Cholangiocarcinoma 04/2024 - 01/2022
5	Inflammation (Inflammations) 03/2024 - 07/2021
3	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 01/2022
3	Liver Diseases (Liver Disease) 01/2023 - 01/2021
2	Colitis 03/2024 - 01/2022
2	Graves Disease (Basedow Disease) 01/2023 - 01/2022
2	Klatskin Tumor 01/2022 - 10/2020
2	Sepsis (Septicemia) 07/2021 - 01/2020
1	Alcoholic Fatty Liver 04/2024
1	Fatty Liver 04/2024
1	Reperfusion Injury 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 04/2024
1	Neoplasm Metastasis (Metastasis) 04/2024
1	Necrosis 11/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Periodontal Pocket (Periodontal Pockets) 04/2022
1	Leprosy (Hansen's Disease) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Hyperoxia 01/2022
1	Lung Injury 07/2021
1	Carcinogenesis 04/2021
1	Colonic Neoplasms (Colon Cancer) 04/2021
1	Lymphatic Metastasis 01/2021
1	Vitiligo 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Osteoporosis 11/2018

Drug/Important Bio-Agent (IBA)

3	Imiquimod (Aldara)FDA LinkGeneric 03/2024 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 10/2023
2	Therapeutic UsesIBA 04/2024 - 03/2024
2	CateninsIBA 04/2024 - 01/2022
2	Circular RNAIBA 01/2024 - 01/2021
2	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022 - 01/2021
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 10/2020
2	Long Noncoding RNAIBA 01/2022 - 04/2021
2	Brefeldin AIBA 07/2021 - 01/2020
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 07/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Sirtuin 1IBA 04/2024
1	mCherry fluorescent proteinIBA 04/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2024
1	2,5-dihydroxybenzoic acid (gentisic acid)IBA 04/2024
1	Protein Isoforms (Isoforms)IBA 04/2024
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2024
1	alcaftadine FDA Link 03/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2024
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 03/2024
1	Interleukin-17 (Interleukin 17)IBA 03/2024
1	Vanillic AcidIBA 03/2024
1	EnzymesIBA 01/2024
1	Ubiquitin-Specific ProteasesIBA 01/2024
1	trametinibIBA 01/2024
1	Gemcitabine FDA Link 11/2023
1	CorticosteroneIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 05/2023
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 05/2023
1	CholesterolIBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	peoniflorinIBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	Bromodeoxyuridine (BrdU)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Claudin-4IBA 01/2022
1	Autophagy-Related ProteinsIBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	tacrolimus binding protein 4 (FKBP52)IBA 01/2022
1	HLA-DQA1 antigen (HLA DQA1)IBA 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 01/2022
1	perfluoropentane (perflenapent)IBA 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2021
1	1,3-di(4-imidazolinophenoxyl)propaneIBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	Adenosine Triphosphate (ATP)IBA 07/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	LipidsIBA 07/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Diphosphonates (Bisphosphonates)IBA 11/2018

Therapy/Procedure

2	Artificial Liver (Bioartificial Liver) 01/2023 - 01/2022
1	Therapeutics 09/2021
1	Punctures 07/2021
1	Ligation 07/2021